Clinical Trial Update: Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants [NA]

View source ↗

Summary

A completed trial compared Veronate with placebo for preventing nosocomial Staphylococcal sepsis in premature infants, assessing safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Nosocomial Infections
• Sepsis
• Staphylococcal Infections

Drugs mentioned

• Veronate (intravenous immunoglobulin (IVIG))

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Nosocomial Infections, Sepsis | NA | Status: COMPLETED